Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;4(1):11-7.
doi: 10.2165/11585530-000000000-00000.

Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond

Mike Baldwin  1 , Andrew Spong, Lynda Doward, Ari Gnanasakthy
Affiliations

Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond

Mike Baldwin et al. Patient. 2011.

Abstract

Internet communication is developing. Social networking sites enable patients to publish and receive communications very easily. Many stakeholders, including patients, are using these media to find new ways to make sense of diseases, to find and discuss treatments, and to give support to patients and their caregivers. We argue for a new definition of patient-reported information (PRI), which differs from the usual patient-reported outcomes (PRO). These new emergent data from the social web have important implications for decision making, at both an individual and a population level. We discuss new emergent technologies that will help aggregate this information and discuss how this will be assessed alongside the use of PROs in randomized controlled trials and how these new emergent data will be one facet of changing the relationship between the various stakeholders in achieving better co-created health.

PubMed Disclaimer

References

    1. Berg S. Herceptin: was patient power key? BBC News 2006 Jun 9 [online]. Available from URL: http://news.bbc.co.uk/1/hi/health/5063352.stm [Accessed 2010 Oct 29]
    1. Acquadro C, Berzon R, Dubois D, et al. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report on the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;5:522–31. doi: 10.1046/j.1524-4733.2003.65309.x. - DOI - PubMed
    1. Burke LB, Kennedy DL, Miskala PH, et al. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther. 2008;84(2):281–3. doi: 10.1038/clpt.2008.128. - DOI - PubMed
    1. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: EMA; 2005. Committee for Medicinal Products for Human use (CMHP)
    1. Burke L. Drug Information Association workshop on Pharmacoeconomics and Quality of Life Labeling and Marketing Claims; 2000 Oct 3; New Orleans (LA) Horsham (PA): Drug Information Association; 2000. Acceptable evidence for pharmaceutical advertising and labeling.

LinkOut - more resources